Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	2,771	1,204	333	1,012	639	958
Market Cap Growth	1114.78%	261.82%	-67.10%	58.27%	-33.29%	107.49%
Enterprise Value	2,461	892.13	109.01	711.76	312.53	473.07
Last Close Price	19.42	8.86	3.09	9.90	7.25	10.94
PE Ratio	-	-10.18	-2.60	-9.17	-5.89	-11.64
PS Ratio	44.42	19.31	7.91	27.70	25.72	25.87
PB Ratio	7.63	3.48	1.67	4.00	2.56	2.78
P/TBV Ratio	6.52	2.97	1.69	3.70	2.55	1.97
P/FCF Ratio	-	-8.61	-2.52	-8.47	-5.47	-15.62
P/OCF Ratio	-	-8.67	-2.53	-8.58	-5.86	-16.10
EV/Sales Ratio	39.46	14.30	2.59	19.49	12.57	12.77
EV/EBITDA Ratio	-	-8.18	-0.76	-6.37	-2.86	-8.26
EV/EBIT Ratio	-	-8.02	-0.75	-6.23	-2.81	-8.13
EV/FCF Ratio	-	-6.38	-0.82	-5.96	-2.68	-7.71
Debt / Equity Ratio	0.09	0.09	0.17	0.15	0.16	0
Debt / EBITDA Ratio	-0.31	-0.31	-0.25	-0.35	-0.38	-0.03
Debt / FCF Ratio	-0.24	-0.24	-0.28	-0.33	-0.35	-0.02
Net Debt / Equity Ratio	-0.89	-0.89	-1.11	-1.18	-1.30	-1.40
Net Debt / EBITDA Ratio	2.84	2.84	1.55	2.67	2.97	8.44
Net Debt / FCF Ratio	2.21	2.21	1.67	2.49	2.78	7.88
Asset Turnover	0.17	0.17	0.12	0.09	0.05	0.10
Quick Ratio	15.83	15.83	6.76	7.33	6.63	11.97
Current Ratio	16.32	16.32	6.98	7.54	6.76	12.10
Return on Equity (ROE)	-37.23%	-37.23%	-57.41%	-40.39%	-36.37%	-30.08%
Return on Assets (ROA)	-31.12%	-31.12%	-40.43%	-27.18%	-23.71%	-16.37%
Return on Invested Capital (ROIC)	-288.72%	-288.72%	-330.47%	-237.83%	-442.50%	-1078.35%
Return on Capital Employed (ROCE)	-33.96%	-33.96%	-45.86%	-30.96%	-26.43%	-18.60%
Earnings Yield	-3.67%	-9.82%	-38.51%	-10.91%	-16.97%	-8.59%
FCF Yield	-5.05%	-11.62%	-39.73%	-11.81%	-18.27%	-6.40%
Buyback Yield / Dilution	-18.48%	-18.48%	-14.32%	-8.10%	-0.25%	-35.81%

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q